
Cefneva-S Injection
Marketer
Geneva Biocare
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Cefneva-S Injection
Cefneva-S Injection, a dual-action medication, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be solely under medical guidance; strictly adhere to the prescribed schedule, completing the full course regardless of symptom improvement. Premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and ample hydration are recommended for optimal recovery. Your physician may order lab tests to monitor treatment response.
Uses of Cefneva-S Injection
Infections caused by bacteria
Major Benefits of Cefneva-S Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefneva-S Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefneva-S Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cefneva-S Injection works:
Ceftriaxone and Sulbactam, the active components of Cefneva-S Injection, act synergistically. Ceftriaxone, a third-generation cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial proliferation. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol ingestion alongside Cefneva-S Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefneva-S is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingCAUTION
The administration of Cefneva-S Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefneva-S Injection could impair alertness, vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data on Cefneva-S Injection use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Cefneva-S Injection requires careful administration in individuals exhibiting severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Cefneva-S Injection is not advised for patients with mild or moderate liver dysfunction.
What if you forget to take Cefneva-S Injection :
Omit a Cefneva-S Injection dose? Seek your physician's advice.
Facts to Know About Cefneva-S Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
